HIV Infection
📧 Sign up to get email alerts when something new happens for HIV Infection.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2015-01-28FDA Approved: KALETRA — Supplemental Application (AbbVie Inc.)
FDA approved a supplemental application for KALETRA (lopinavir and ritonavir) from AbbVie, resulting in an updated regulatory action for the…
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection [Phase 1]
This document reports the completion of a Phase 1 safety and immunogenicity trial of a recombinant Modified Vaccinia Virus Ankara (MVA)–base…
-
CLINICAL_TRIALS trial_result · 2015-01-27Clinical Trial Update: INNOVE Study: A Study of 3 Months Induction With Fuzeon (Enfuvirtide) + Optimized Background (OB) Versus OB Alone in HIV-1 Infected Patients With Virological Failure. [Phase 2]
Phase 2 INNOVE study comparing 3 months of induction with Fuzeon (enfuvirtide) plus optimized background therapy versus optimized background…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Study to Evaluate Switching From Regimens Consisting of a Ritonavir-boosted Protease Inhibitor Plus Emtricitabine/Tenofovir Fixed-Dose Combination to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients [Phase 3]
Phase 3 trial evaluating switching virologically suppressed HIV-1 patients from a ritonavir-boosted protease inhibitor plus emtricitabine/te…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Effect Of A CCR5 Coreceptor Antagonist On The Latency And Reservoir Of HIV-1 [Phase 2]
A Phase 2 study evaluating whether a CCR5 coreceptor antagonist can influence HIV-1 latency and viral reservoirs has been completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Study to Evaluate Switching From Regimens Consisting of a Nonnucleoside Reverse Transcriptase Inhibitor Plus Emtricitabine and Tenofovir DF to the Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Single-Tablet Regimen in Virologically Suppressed, HIV-1 Infected Patients [Phase 3]
Phase 3 trial evaluating switching virologically suppressed HIV-1-infected patients from regimens containing an NNRTI plus Emtricitabine and…
-
CLINICAL_TRIALS trial_result · 2015-01-26Clinical Trial Update: Stepping Stones Program for Preventing HIV Infection in Residents of Rural South African Communities [Phase 3]
This is a Phase 3 clinical trial update on the Stepping Stones program, an HIV prevention intervention in rural South African communities. T…
-
CLINICAL_TRIALS research · 2015-01-21Clinical Trial Update: Improving Uptake of Early Infant Diagnosis of HIV for the Prevention of Mother-to-child Transmission of HIV [NA]
The University of Washington–sponsored clinical trial evaluated strategies to improve uptake of early infant diagnosis of HIV to prevent mot…
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: A Pilot Study to Examine Efficacy of Peer Mentoring in Promoting Medication Adherence Among People Living With HIV/AIDS [NA]
A pilot clinical trial is examining whether peer mentoring can improve medication adherence among people living with HIV/AIDS.
-
CLINICAL_TRIALS trial_result · 2015-01-21Clinical Trial Update: Non-interventional Observational Study With Viramune® in HIV to Evaluate Gender Specific Data
A completed non-interventional observational study evaluated gender-specific data for nevirapine (Viramune) in HIV treatment.
-
FDA approval · 2015-01-20FDA Approved: NEVIRAPINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for Nevirapine from Aurobindo Pharma Limited.
-
CLINICAL_TRIALS trial_result · 2015-01-19Clinical Trial Update: Representations and Acceptability of HIV Therapeutic Vaccine in a Cohort of HIV-1 Infected Outpatients Followed at Hospital [NA]
The update assesses representations and acceptability of an HIV therapeutic vaccine in HIV-1 infected outpatients at Hospital Foch. The tria…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients [NA]
A completed clinical trial evaluating the safety and effectiveness of clarithromycin for preventing Mycobacterium avium complex infection in…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS [NA]
A completed clinical trial evaluated the safety and effectiveness of adding clofazimine to clarithromycin plus ethambutol for treating Mycob…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Text Messaging to Improve Adherence to Clinic Visits and Reduce Early Resumption of Sexual Intercourse After Male Circumcision [NA]
This Clinical Trial Update reports completion of a study evaluating text messaging to improve adherence to clinic visits and reduce early re…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: Non-Interventional Observational Study With Viramune Plus Antiretroviral in HIV Infected Patients
This is a completed non-interventional observational study evaluating Viramune (nevirapine) plus antiretrovirals in HIV-infected patients, w…
-
CLINICAL_TRIALS trial_result · 2015-01-16Clinical Trial Update: A Study of Decreased Mental Function Associated With HIV [NA]
A completed clinical trial investigated decreased mental function associated with HIV.
-
CLINICAL_TRIALS trial_result · 2015-01-15Clinical Trial Update: Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected Patients [Phase 2, Phase 3]
A Phase 2/3 clinical trial update reports on the efficacy and tolerability of adding pegylated interferon alfa-2a to the standard HIV/HBV re…
-
FDA approval · 2015-01-15FDA Approved: RITONAVIR FILM COATED — Original Application (Cipla USA Inc.)
The FDA approved Ritonavir Film Coated 100 mg as an Original Application (ANDA) for Cipla USA Inc., a generic ritonavir product. This marks …
-
CLINICAL_TRIALS trial_result · 2015-01-14Clinical Trial Update: Efficacy of Pegylated Interferon Plus Ribavirin Plus Nitazoxanide in HCV Genotype 4 and HIV Coinfection [Phase 2]
Phase 2 clinical trial evaluating the efficacy of pegylated interferon plus ribavirin plus nitazoxanide in patients with Hepatitis C genotyp…
-
CLINICAL_TRIALS research · 2015-01-13Clinical Trial Update: Developing and Assessing a Community Based Model of Antiretroviral Care [NA]
This document provides an update on developing and assessing a community-based model of antiretroviral care for HIV. It describes ongoing ef…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Safety, Tolerability,and Adherence to Co-formulated Tenofovir-emtricitabine-rilpivirine Used as HIV Nonoccupational Post-exposure Prophylaxis in Men Who Have Sex With Men. [Phase 4]
This Phase 4 clinical trial update reports on the safety, tolerability, and adherence of a fixed-dose combination of tenofovir disoproxil fu…
-
CLINICAL_TRIALS trial_result · 2015-01-12Clinical Trial Update: Post-prandial Lipid Effects of Raltegravir (RAL) vs Ritonavir -Boosted Darunavir (DRV-r) in Anti-retroviral Therapy (ART)- Naive Adults or Adults Recommencing ART. [Phase 4]
A Phase 4 trial comparing post-prandial lipid effects of raltegravir versus ritonavir-boosted darunavir in ART-naive or ART-recommencing adu…
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: Alcohol Harm Reduction Intervention Among Female Sex Workers in Mombasa, Kenya [NA]
Clinical trial update reporting a completed behavioral alcohol harm reduction study among female sex workers in Mombasa, Kenya, addressing a…
-
CLINICAL_TRIALS trial_result · 2015-01-09Clinical Trial Update: Male Engagement in PMTCT Services [NA]
The clinical trial on male engagement in PMTCT services sponsored by FHI 360 has completed. The snippet does not provide trial results.